A coalition of small and medium-sized composites manufacturers have urged the White House to commission a National Academy of Sciences (NAS) review of HHS’ listing of the chemical styrene in its Twelfth Report on Carcinogens (RoC).
“HHS’ action has unfairly placed hundreds of small business owners across the country in the untenable position of having to explain to employees and plant neighbours that we use styrene safely,” the coalition told White House Chief of Staff William Daley in a letter. The composites industry’s request for an independent NAS study is “driven by the conflict of authorities both within and outside of the federal government regarding the health effects of styrene, and public confusion that has resulted from HHS’ listing of styrene in the RoC,” the group told Daley.
The coalition says that during HHS’ assessment of styrene it failed to “fairly and transparently” address the breadth of scientific data available on styrene, the preponderance of which, including exhaustive studies by the European Union, Health Canada, and a blue-ribbon panel of scientists affiliated with the Harvard School of Public Health, shows no causal link between styrene and cancer. “The public confusion is exacerbated not just due to the scientific controversy, but because of conflicting statements by HHS staff,” the letter pointed out.
According to the coalition, HHS guidance documents maintain that a listing in the RoC does notindicate that anyone’s health is actually at risk. Moreover, during a recent press conference, HHS scientists further confused the safety issue by saying they are not advocating that workers or consumers change their behaviour in the wake of the styrene ruling, but only to “be aware of” the purported cancer link for styrene.
“A definitive carcinogenicity hazard assessment on styrene from the respected and independent National Academy of Sciences would go a long way towards settling the scientific controversy and allow the Administration to provide responsible guidance to workers and members of the public,” the letter said.
“Left unchallenged, we expect the HHS styrene listing in the 12th Edition of the Report on Carcinogens (RoC) in mid-June to have the long-term effect of moving manufacturing jobs to Mexico, China, France or one of the many other countries that have not taken such an obviously misleading position regarding styrene.”
For more information visit:
Subscribe to receive our weekly round-up of all the industry's latest news, jobs, events and more!